Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Cash from Operations (2016 - 2025)

Elite Health Systems' Cash from Operations history spans 16 years, with the latest figure at 1492000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 1492000.0 for Q4 2025, down 183.11% from a year ago — trailing twelve months through Dec 2025 was 2940000.0 (down 94.06% YoY), and the annual figure for FY2025 was 2940000.0, down 94.06%.
  • Cash from Operations for Q4 2025 was 1492000.0 at Elite Health Systems, down from 817000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 421000.0 in Q2 2021 to a low of 1492000.0 in Q4 2025.
  • The 5-year median for Cash from Operations is 308500.0 (2023), against an average of 329250.0.
  • The sharpest move saw Cash from Operations skyrocketed 175.64% in 2023, then crashed 1034.72% in 2025.
  • Year by year, Cash from Operations stood at 268000.0 in 2021, then decreased by 1.49% to 272000.0 in 2022, then decreased by 17.65% to 320000.0 in 2023, then tumbled by 64.69% to 527000.0 in 2024, then plummeted by 183.11% to 1492000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 1492000.0, 817000.0, and 334000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.